Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA)
Condition(s):Multiple SclerosisLast Updated:February 16, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Multiple SclerosisLast Updated:February 16, 2024Recruiting
Condition(s):Multiple Sclerosis, Secondary Progressive; Multiple SclerosisLast Updated:July 28, 2023Recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:April 29, 2022Recruiting
Condition(s):Multiple Sclerosis, Relapsing-RemittingLast Updated:January 8, 2024Active, not recruiting
Condition(s):Multiple SclerosisLast Updated:February 8, 2024Active, not recruiting
Condition(s):Multiple SclerosisLast Updated:January 12, 2024Active, not recruiting
Condition(s):Leukemia, Myeloid, Acute; Leukemia, Lymphoblastic, AcuteLast Updated:June 28, 2018Unknown status
Condition(s):Multiple SclerosisLast Updated:January 13, 2022Recruiting
Condition(s):Leukemia; Myelodysplastic Syndromes; Acute Myeloid LeukemiaLast Updated:February 8, 2024Active, not recruiting
Condition(s):Multiple Sclerosis; Multiple Sclerosis, Relapsing-RemittingLast Updated:March 22, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.